Mindfulness-based cognitive therapy for generalized anxiety disorder
Mindfulness-based cognitive therapy for generalized anxiety disorder
复制标题
DOI：
10.1016/j.janxdis.2007.07.005
复制
发表时间：
2008-05-01
影响因子：
10.3
通讯作者：
Haglin, Dean
中科院分区：
文献类型：
--
作者：
Evans, Susan;Ferrando, Stephen;Haglin, Dean
虽然认知行为疗法已被发现对广泛性焦虑障碍（GAD）的治疗有效，但仍有相当比例的患者受残留症状困扰。有一些理论依据表明，正念的培养可能对广泛性焦虑障碍患者有益。正念认知疗法（MBCT）是一种源自乔恩·卡巴金及其同事所开发的正念减压疗法（MBSR）的团体治疗方法。正念减压疗法将正念冥想训练作为该项目的核心。正念认知疗法融合了认知策略，并已被发现在减少重性抑郁症患者的复发方面是有效的（蒂斯代尔，J.D.，西格尔，Z.V.，威廉姆斯，J.M.G.，里奇韦，V.，索尔兹比，J.，&刘，M.（2000年）。正念认知疗法对重性抑郁症复发的预防。《咨询与临床心理学杂志》，6，615 - 623页）。
方法：被招募到一家大型学术医疗中心的符合条件的受试者参加了正念认知疗法团体课程，并在基线和治疗结束时完成了对焦虑、担忧、抑郁症状、情绪状态以及日常生活中的正念意识的测量。
结果：11名受试者（6名女性和5名男性）平均年龄为49岁（范围为36 - 72岁）符合标准并完成了研究。从基线到治疗结束，焦虑和抑郁症状显著减轻。
结论：正念认知疗法可能是一种可接受且潜在有效的治疗方法，可用于减轻广泛性焦虑障碍患者的焦虑和情绪症状，并提高其对日常体验的意识。未来的方向包括开展一项针对广泛性焦虑障碍的正念认知疗法的随机临床试验。（c）2007爱思唯尔有限公司。保留所有权利。
While cognitive behavior therapy has been found to be effective in the treatment of generalized anxiety disorder (GAD), a significant percentage of patients struggle with residual symptoms. There is some conceptual basis for suggesting that cultivation of mindfulness may be helpful for people with GAD. Mindfulness-based cognitive therapy (MBCT) is a group treatment derived from mindfulness-based stress reduction (MBSR) developed by Jon Kabat-Zinn and colleagues. MBSR uses training in mindfulness meditation as the core of the program. MBCT incorporates cognitive strategies and has been found effective in reducing relapse in patients with major depression (Teasdale, J. D., Segal, Z. V., Williams, J. M. G., Ridgeway, V., Soulsby, J., & Lau, M. (2000). Prevention of relapse/ recurrence in major depression by mindfulness-based cognitive therapy. Journal of Consulting and Clinical Psychology, 6,615-623).Method: Eligible subjects recruited to a major academic medical center participated in the group MBCT course and completed measures of anxiety, worry, depressive symptoms, mood states and mindful awareness in everyday life at baseline and end of treatment.Results: Eleven subjects (six female and five male) with a mean age of 49 (range = 36-72) met criteria and completed the study. There were significant reductions in anxiety and depressive symptoms from baseline to end of treatment. Conclusion: MBCT may be an acceptable and potentially effective treatment for reducing anxiety and mood symptoms and increasing awareness of everyday experiences in patients with GAD. Future directions include development of a randomized clinical trial of MBCT for GAD. (c) 2007 Elsevier Ltd. All rights reserved.